Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HBM Healthcare InvestmentsHBMBF 30 Intrinsic Value: Projected FCF is $316.12 as of Sep. 04, 2026. GuruFocus rates HBMBF with a GF Score™ of 30/100. The stock has 4 warning signs investors should review. Among 1,216 Asset Management companies, HBM Healthcare Investments ranks worse than 52.88% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for HBM Healthcare Investments's Intrinsic Value: Projected FCF or its related term are showing as below:
HBMBF'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.9 Med: 1.1 Max: 1.39
Current: 0.98
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of HBM Healthcare Investments was 1.39. The lowest was 0.90. And the median was 1.10.
HBMBF's Price-to-Projected-FCF is ranked worse than 52.88% of 1216
companies
in the Asset Management industry
Industry Median: 0.9
vs HBMBF: 0.98
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
HBM Healthcare Investments's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
308.91
/
300.25950450966
=
1.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HBM Healthcare Investments Intrinsic Value: Projected FCF Related Terms
HBM Healthcare Investments Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for HBM Healthcare Investments's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HBMBF vs BLK, BX, KKR: Intrinsic Value: Projected FCF Comparison
For the Asset Management subindustry, HBM Healthcare Investments's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HBM Healthcare Investments Price-to-Projected-FCF vs Asset Management Industry
For the Asset Management industry and Financial Services sector, HBM Healthcare Investments's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where HBM Healthcare Investments's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $316.12 mean?
HBM Healthcare Investments (HBMBF) has a Intrinsic Value: Projected FCF of $316.12 as of Sep. 04, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on HBM Healthcare Investments and its competitors. According to the industry distribution chart, HBM Healthcare Investments ranks #643 out of 1216 companies in the Asset Management industry, placing it in the top 52.9%.
Is HBM Healthcare Investments' Intrinsic Value: Projected FCF too high?
HBM Healthcare Investments' current Intrinsic Value: Projected FCF is $316.12. The Asset Management industry median Intrinsic Value: Projected FCF is 0.90. HBM Healthcare Investments' value of $316.12 is 35024.4% above this industry median. Based on the distribution chart, HBM Healthcare Investments ranks #643 out of 1216 companies in the Asset Management industry, which is below the industry midpoint. Overall, HBM Healthcare Investments has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does HBM Healthcare Investments' Intrinsic Value: Projected FCF compare to BLK and BX?
According to the Asset Management industry distribution chart, HBM Healthcare Investments ranks #643 out of 1216 companies for Intrinsic Value: Projected FCF. This places HBM Healthcare Investments in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 0.90. HBM Healthcare Investments' value of $316.12 is 35024.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for an Asset Management company?
The median Intrinsic Value: Projected FCF among Asset Management companies is 0.90, based on 1,216 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HBM Healthcare Investments's current Intrinsic Value: Projected FCF of $316.12 is 35024.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on HBM Healthcare Investments and its competitors. For the Asset Management industry, the median Intrinsic Value: Projected FCF is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HBM Healthcare Investments's current Intrinsic Value: Projected FCF is $316.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HBM Healthcare Investments stock overvalued right now?
HBM Healthcare Investments (HBMBF) has a current Intrinsic Value: Projected FCF of $316.12. The current Intrinsic Value: Projected FCF is $316.12 and 35024.4% above the Asset Management industry median of 0.90. HBM Healthcare Investments' overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For HBM Healthcare Investments (HBMBF), the current Intrinsic Value: Projected FCF is $316.12 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
30GF Score
Get the complete analysis for HBMBF
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HBMBF has been successfully added to your 
